LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $299,600 | -16.9% | 5,000 | 0.0% | 0.05% | -11.5% |
Q2 2023 | $360,500 | -2.0% | 5,000 | 0.0% | 0.05% | -8.8% |
Q1 2023 | $367,800 | +10.1% | 5,000 | 0.0% | 0.06% | +5.6% |
Q4 2022 | $334,000 | -22.5% | 5,000 | 0.0% | 0.05% | -27.0% |
Q3 2022 | $431,000 | -3.4% | 5,000 | 0.0% | 0.07% | +1.4% |
Q2 2022 | $446,000 | -20.6% | 5,000 | 0.0% | 0.07% | -3.9% |
Q1 2022 | $562,000 | -27.2% | 5,000 | 0.0% | 0.08% | -21.6% |
Q4 2021 | $772,000 | +10.8% | 5,000 | 0.0% | 0.10% | +2.1% |
Q3 2021 | $697,000 | +6.2% | 5,000 | 0.0% | 0.10% | +9.2% |
Q2 2021 | $656,000 | -13.9% | 5,000 | 0.0% | 0.09% | -19.4% |
Q1 2021 | $762,000 | +53.3% | 5,000 | 0.0% | 0.11% | +40.3% |
Q4 2020 | $497,000 | +4.2% | 5,000 | 0.0% | 0.08% | -10.5% |
Q3 2020 | $477,000 | -14.7% | 5,000 | 0.0% | 0.09% | -18.1% |
Q2 2020 | $559,000 | +53.6% | 5,000 | 0.0% | 0.10% | +26.5% |
Q1 2020 | $364,000 | -30.1% | 5,000 | 0.0% | 0.08% | -5.7% |
Q4 2019 | $521,000 | +4.6% | 5,000 | 0.0% | 0.09% | -3.3% |
Q3 2019 | $498,000 | -12.8% | 5,000 | 0.0% | 0.09% | -10.8% |
Q2 2019 | $571,000 | -9.2% | 5,000 | 0.0% | 0.10% | -10.5% |
Q1 2019 | $629,000 | +54.5% | 5,000 | +66.7% | 0.11% | +34.1% |
Q4 2018 | $407,000 | -17.6% | 3,000 | +66.7% | 0.08% | +1.2% |
Q3 2018 | $494,000 | +19.3% | 1,800 | -10.0% | 0.08% | +13.5% |
Q2 2018 | $414,000 | -58.2% | 2,000 | -66.7% | 0.07% | -58.2% |
Q1 2018 | $991,000 | +20.6% | 6,000 | 0.0% | 0.18% | +24.6% |
Q4 2017 | $822,000 | +50.8% | 6,000 | +50.0% | 0.14% | +43.4% |
Q3 2017 | $545,000 | -32.6% | 4,000 | -40.0% | 0.10% | -35.3% |
Q2 2017 | $809,000 | +14.6% | 6,666 | 0.0% | 0.15% | +14.2% |
Q1 2017 | $706,000 | +4.3% | 6,666 | 0.0% | 0.13% | -0.7% |
Q4 2016 | $677,000 | -0.4% | 6,666 | 0.0% | 0.14% | -4.3% |
Q3 2016 | $680,000 | -14.5% | 6,666 | 0.0% | 0.14% | -16.6% |
Q2 2016 | $795,000 | +1.7% | 6,666 | 0.0% | 0.17% | +1.8% |
Q1 2016 | $782,000 | +8.2% | 6,666 | 0.0% | 0.17% | +12.2% |
Q4 2015 | $723,000 | +26.6% | 6,666 | 0.0% | 0.15% | +19.4% |
Q3 2015 | $571,000 | -15.2% | 6,666 | 0.0% | 0.12% | -5.3% |
Q2 2015 | $673,000 | +30.9% | 6,666 | 0.0% | 0.13% | +32.3% |
Q1 2015 | $514,000 | +44.8% | 6,666 | 0.0% | 0.10% | +43.5% |
Q4 2014 | $355,000 | +13.4% | 6,666 | 0.0% | 0.07% | +7.8% |
Q3 2014 | $313,000 | -24.6% | 6,666 | 0.0% | 0.06% | -22.0% |
Q2 2014 | $415,000 | -7.4% | 6,666 | 0.0% | 0.08% | -10.9% |
Q1 2014 | $448,000 | – | 6,666 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |